logo-loader
RNS
Cello Health PLC

Cello Health PLC - Additional Block Listing of Ordinary Shares

RNS Number : 5348V
Cello Health PLC
07 August 2020
 

7 August 2020

Cello Health plc

("Cello" or the "Company")

Additional Block Listing of Ordinary Shares

 

Following the Court Hearing held earlier today in connection with the cash acquisition of Cello Health plc by Pharma Value Demonstration Bidco Limited, the Company announces that an application has been made for a block admission for 2,421,000 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.

 

These new Ordinary Shares will be issued and allotted pursuant to the exercise of existing options under the Company's Performance Share Plan 2010, the HM Revenue & Customs Approved Company Share Option Plan and its Unapproved Share Option Plan. New Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company.

 

Admission of the new Ordinary Shares is expected to occur on 10 August 2020.

 

 

Enquires

Cello Health

020 7812 8460

Mark Scott, Chief Executive


Mark Bentley, Group Finance Director




Cenkos Securities

  020 7397 8900

Giles Balleny


Harry Hargreaves




Buchanan

  020 7466 5000

Mark Court


Jamie Hooper


Sophie Wills


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSEAFPXELNEEFA
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read